Hectic lifestyles and exposure to toxic materials can adversely impact the eyesight of people, which is why they are compelled to strive for a healthy vision. Growing need to maintain that perfect “20/20” eyesight has spiked the demand for eye health supplements.
Prevalence of cataracts, macular degeneration, glaucoma and many other eye diseases is prompting people to get eye health supplements prescribed from their ophthalmologists. For visually-impaired people, eye specialists are also promoting the benefits of regularised consumption of eye health supplements in order to safeguard the remainder of their eyesight. Persistence Market Research’s recently published report on the global eye health supplements market projects that by the end of 2024, more than US$ 2.85 Bn worth of eye health supplements will be sold across the globe.
Factors driving the adoption of eye health supplements include:
In the report, titled “Eye Health Supplements Market: Global Industry Analysis and Forecast, 2016-2024,” companies such as Vitabiotics Ltd., Valeant Pharmaceuticals International Inc., Alliance Pharma, Novartis AG, Amway Corp., Pfizer Inc., and The Nature’s Bounty Co. are profiled as leading manufacturers & suppliers of eye health supplements in the world. These companies are spanned across North America and Europe, making these regions highly lucrative for eye health supplements market. Key findings in the report indicate that North America will dominate the global market with more than 30% revenue share, while Europe’s eye health supplements market will exhibit speedy revenue growth at 6.3% CAGR. Meanwhile, with 6.7% CAGR, the Asia-Pacific excluding Japan region will record impressive sales of eye health supplements through 2024.
The report further reveals that demand for eye health supplements containing antioxidants and lutein & zeaxanthin as core ingredients will remain fairly higher. By accounting for more than 60% share, demand for these ingredients will continue gain traction during the forecast period. And, it has been projected that more than two-third of eye health supplements produced in the world will be used for treatment of age-induced macular degeneration. Consumers of eye health supplements are also expected to prefer tablet supplements as opposed to capsules. In 2016, around US$ 587 Mn worth of tablet supplements were sold in the global market for eye health supplements.
This content was originally published here.